Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Cancer Gene Ther ; 24(1): 28-32, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27982018

RESUMEN

In this study, the anticancer property of SiO2@antisense molecules (SiO2@AMs) and SiO2@AM covered by nepetalactone (SiO2@AM/CN), extracted from Nepeta gloeocephala, was investigated. Here integrin-linked kinase (ILK) phosphorylation and protein kinase B/AKT (PKB/AKT) signaling was studied when HeLa cells were exposed to SiO2@AM and SiO2@AM/CN. First, N. gloeocephala was identified at the Iranian National Herbarium. Then, its essential oil (EO) was obtained by the hydrodistillation method. In the next step, 4aα,7α,7aα-nepetalactone was extracted from the EO, based on the spectroscopic data. To obtain SiO2@AM/CN, 1 ml of SiO2@AM was mixed with extracted nepetalactone and then strongly shaken for 30 min. Finally, serial concentrations (100, 50, 25 and 12.5 µg ml-1) of SiO2@AM and SiO2@AM/CN were prepared and then exposed to HeLa cells (2 × 105 cells per ml) for 24 h at 37 °C. After incubation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, cell-cycle analysis, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay and western blots were carried out. To find ILK phosphorylation and PKB/AKT signaling, the expression of threonine-173 (Thr-173), serine-246 (Ser-246), total ILK, AKT-Ser473, AKT-Thr308 and total AKT was investigated. HeLa cells that were treated with SiO2@AM/CN had G2/M arrest. Based on the TUNEL assay, many apoptotic cells have been shown when they were exposed to SiO2@AM/CN. Importantly, SiO2@AM/CN decreased ILK phosphorylation at Thr-173 and Ser-246 without affecting total ILK levels. Moreover, SiO2@AM/CN decreased AKT-Ser473 and AKT-Thr308 phosphorylation without affecting total PKB/AKT protein.


Asunto(s)
Ciclopentanos , Nepeta/química , Extractos Vegetales/farmacología , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Pironas , Transducción de Señal/efectos de los fármacos , Dióxido de Silicio , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Monoterpenos Ciclopentánicos , Células HeLa , Humanos , Fosforilación/efectos de los fármacos , Extractos Vegetales/química , Dióxido de Silicio/química
2.
J Plast Reconstr Aesthet Surg ; 69(1): 42-7, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26601878

RESUMEN

Prolonged abdominal drainage after perforator-based breast reconstruction is a common problem that can result in seroma formation, patient morbidity, and increased duration of hospital stay. Abdominal quilting with progressive tension sutures has been effective in reducing abdominal drainage in abdominoplasty patients prompting a change of practice in our unit. We studied consecutive unilateral mastectomy patients undergoing breast reconstruction with a deep inferior epigastric artery perforator (DIEP) flap. The initial 27 patients underwent breast reconstruction without any form of abdominal flap plication. The subsequent 26 patients underwent an identical DIEP flap raise procedure after which the abdominal flap was progressively tensioned using a running barbed suture quilting technique. All patients had closed suction drains inserted bilaterally until daily drain output was <40 ml in 2 consecutive days. Primary outcome measures were total volume of abdominal drainage and length of hospital stay. Independent statistical analyses were performed using Welch's t-test. There were no demographic differences between the two groups. A statistically significant decrease in the mean total abdominal drainage was found after quilting (238 ml vs. 528 ml; p = 0.0005). Patients in the quilting group also showed a reduction in mean duration of hospital stay. Quilting of the abdominal flap helps to reduce abdominal drainage not only in abdominoplasty patients but also in patients undergoing breast reconstruction with DIEP flap.


Asunto(s)
Abdominoplastia/métodos , Drenaje/métodos , Arterias Epigástricas/cirugía , Mamoplastia/métodos , Colgajo Perforante , Técnicas de Sutura/instrumentación , Suturas , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Mamoplastia/efectos adversos , Persona de Mediana Edad , Estudios Retrospectivos , Seroma/etiología , Seroma/prevención & control , Sitio Donante de Trasplante/cirugía
4.
J Pediatr Surg ; 50(9): 1517-20, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25783323

RESUMEN

OBJECTIVE: The success of in utero hematopoietic cell transplantation (IUHCTx) hinges on successful conditioning strategies of the host to overcome barriers to engraftment. The "space" barrier is a reflection of a finite number of hematopoietic stem cell (HSC) niches within the host. Independent of the number of donor HSCs transplanted, engraftment is frequently low. By conditioning fetal mice using a monoclonal antibody against the c-kit receptor (ACK2) found on HSCs, we can effectively increase space for donor HSC engraftment. We questioned whether simple placental injection of ACK2 early in gestation could effectively deplete host HSCs within the fetal liver and neonatal bone marrow. METHODS: In this set of experiments, we injected mice with ACK2 (5 µg/fetus) or PBS at E11.5-12.5 and harvested the fetal liver at 2 and 4 days and the neonatal bone marrow at 7 days following injection. Survival and total number of HSCs within the fetal liver or bone marrow were quantified and compared. RESULTS: Survival between the treated and control group was similar (73% and 71%, respectively). The total number of HSCs within the fetal liver was not significantly lower following ACK2 treatment compared to PBS injected fetuses at 2 days but was by 4 days. Additionally, ACK2 resulted in a significant reduction in the number of HSCs within neonatal mice 7 days after treatment. CONCLUSION: Survival following placental ACK2 injection is comparable to control animals and provides a simple non-invasive strategy to deliver ACK2 into the fetal circulation which successfully depletes the host HSCs.


Asunto(s)
Anticuerpos Monoclonales/administración & dosificación , Terapias Fetales/métodos , Trasplante de Células Madre Hematopoyéticas/métodos , Placenta , Acondicionamiento Pretrasplante/métodos , Animales , Anticuerpos Monoclonales/farmacología , Anticuerpos Monoclonales/uso terapéutico , Médula Ósea/efectos de los fármacos , Femenino , Feto/citología , Células Madre Hematopoyéticas/efectos de los fármacos , Inyecciones , Hígado/citología , Ratones , Ratones Endogámicos C57BL , Embarazo , Proteínas Proto-Oncogénicas c-kit/inmunología
5.
Endocrinology ; 138(3): 1305-11, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9048640

RESUMEN

11 beta-Hydroxysteroid dehydrogenase (11 beta HSI) is an enzyme complex responsible for the conversion of hormonally active cortisol to inactive cortisone; two isoforms of the enzyme have been cloned and characterized. Clinical observations from patients with the hypertensive syndrome apparent mineralocorticoid excess, recently explained on the basis of mutations in the human 11 beta HSD2 gene, suggest that it is the 11 beta HSD2 isoform that serves a vital role in dictating specificity upon the mineralocorticoid receptor (MR). We have raised a novel antibody in sheep against human 11 beta HSD2 using synthetic multiantigenic peptides and have examined the localization and subcellular distribution of 11 beta HSD2 in mineralocorticoid target tissues. The immunopurified antibody recognized a single band of approximately 44 kDa in placenta, trophoblast, and distal colon. In kidney tissue, two bands of approximately 44 and 48 kDa were consistently observed. No signal was seen in decidua, adrenal, or liver. Immunoperoxidase studies on the mineralocorticoid target tissues, kidney, colon, and parotid gland indicated positive staining in epithelial cells known to express the MR: respectively, renal collecting ducts, surface and crypt colonic epithelial cells, and parotid duct epithelial cells. No staining was seen in these tissues in other sites. The intracellular localization of 11 beta HSD2 in kidney and colon epithelial cells was addressed using confocal laser microscopy. Parallel measurements of 11 beta HSD2 and nuclear propidium iodide fluorescence on sections scanned through an optical section of approximately 0.1 micron indicated significant 11 beta HSD2 immunofluorescence in the nucleus. In human kidney, colon, and salivary gland, 11 beta HSD2 protects the MR from glucocorticoid excess in an autocrine fashion. Furthermore, within these tissues, 11 beta HSD2, which had been considered to be a microsomal enzyme, is also found in the nucleus, suggesting that the interaction between the MR and aldosterone or cortisol is in part a nuclear event.


Asunto(s)
Núcleo Celular/metabolismo , Colon/metabolismo , Hidroxiesteroide Deshidrogenasas/metabolismo , Isoenzimas/metabolismo , Riñón/metabolismo , Glándulas Salivales/metabolismo , 11-beta-Hidroxiesteroide Deshidrogenasas , Animales , Western Blotting , Humanos , Inmunohistoquímica , Microscopía Confocal , Mineralocorticoides/fisiología , Distribución Tisular
6.
Br J Ophthalmol ; 88(9): 1159-62, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15317708

RESUMEN

BACKGROUND/AIMS: Uveitis is a major cause of visual morbidity in the working age group. The authors investigated the duration, degree, and causes of visual loss in uveitis patients with the aim of better defining the visual morbidity and identifying potential risk factors. METHODS: A retrospective, non-interventional, observational survey of 315 consecutive patients attending a tertiary referral uveitis service. RESULTS: The mean duration of follow up was 36.7 months. Reduced vision (< or =6/18) was found in 220/315 (69.95%) of the patients with a subset of 120 patients having vision < or =6/60. Unilateral visual loss occurred in 109 (49.54%), while 111 (50.45%) had bilateral loss. The mean duration of visual loss was 21 months. Of the 148 patients with pan-uveitis, 125 (84.45%) had reduced vision, with 66 (53%) having vision < or =6/60. Main causes of visual loss were cystoid macular oedema (CMO) (59/220, 26.8%), cataract (39/220, 17.7%), and combination of CMO and cataract (44/220, 20%). The following were predictive of a poorer visual prognosis: pan-uveitis (p = 0.0005), bilateral inflammation (p = 0.0005), increasing duration of reduced vision (p = 0.0005), an Indian or Pakistani ethnic background (p = 0.004), and increasing patient age (p = 0.02). CONCLUSION: Prolonged visual loss occurred in two thirds of uveitis patients, with 70 (22%) patients meeting the criteria for legal blindness at some point in their follow up. Older patients with bilateral inflammation and an increasing duration of reduced vision are at the greatest risk of severe visual loss (< or =6/60). CMO and cataract were responsible for visual loss in 64.5% of patients.


Asunto(s)
Uveítis/complicaciones , Trastornos de la Visión/etiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Catarata/complicaciones , Niño , Enfermedad Crónica , Femenino , Humanos , Edema Macular/complicaciones , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo
7.
J Surg Case Rep ; 2012(7): 8, 2012 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-24960733

RESUMEN

Dermatofibrosarcoma protuberans (DFSP) is an uncommon, locally aggressive, soft tissue tumour. Occurrence in the head and neck region is rare and facial presentations are even rarer. We present a case of a DFSP in a young gentleman with the oncological, functional and aesthetic challenges that arose from the case. We also reviewed the relevant literature on DFSP pertaining to the head and neck region and devised a treatment algorithm based on the best available evidence.

8.
Hand Surg ; 17(3): 325-30, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23061940

RESUMEN

Patients presenting with distal end radius fractures may have concomitant carpal instability due to disruption of the scapholunate ligament. This study examined the incidence of static radiographic signs of carpal instability in patients with distal radial fractures before and after fracture treatment. We performed a retrospective radiographic study of 141 patients presenting to Central Middlesex Hospital, London between January 2002-May 2004 with distal end radius fractures. We used abnormal scapholunate angle as the primary indicator of possible carpal dissociation. Abnormal scapholunate angles were noted in 39% of patients at presentation and 35% of patients after treatment with no statistically significant intra-patient variability. Persistent static radiographic signs of carpal instability are high in this subset of patients. The long-term morbidity of persistent wrist instability may be avoided by early radiological diagnosis with clinical correlation to identify carpal ligament injuries and initiate treatment that addresses both the bony and ligamentous components of the injury.


Asunto(s)
Huesos del Carpo/lesiones , Fijación de Fractura/métodos , Inestabilidad de la Articulación/diagnóstico por imagen , Fracturas del Radio/diagnóstico por imagen , Traumatismos de la Muñeca/diagnóstico por imagen , Adulto , Anciano , Anciano de 80 o más Años , Huesos del Carpo/diagnóstico por imagen , Femenino , Humanos , Inestabilidad de la Articulación/etiología , Inestabilidad de la Articulación/terapia , Masculino , Persona de Mediana Edad , Radiografía , Fracturas del Radio/complicaciones , Fracturas del Radio/terapia , Estudios Retrospectivos , Resultado del Tratamiento , Traumatismos de la Muñeca/complicaciones , Traumatismos de la Muñeca/terapia , Adulto Joven
9.
J Plast Reconstr Aesthet Surg ; 64(6): 710-5, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21112263

RESUMEN

A retrospective audit was performed of patients undergoing breast reconstruction under the care of the senior author from 2000 to 2007. We documented reconstruction type, length of stay and total number of revisions. Income to the trust based on the 2008/9 HRG codes along with any "top ups" was also recorded. This was compared to calculations of cost to the trust of performing each reconstruction. 274 patients had 278 primary reconstructions and a further 366 revisions. Only patients with a minimum one-year's follow-up were included (mean 3 years). This included 68 DIEPs'; 39 TRAMs'; 98 LDs'; and 73 implant reconstructions. The median length of stay for implant based reconstruction was 4 days; 9 for LD flaps; 11 for TRAMs' and 8 for DIEPs'. This was significantly shorter for the implant group compared to other reconstructions (P<0.001). The mean number of surgical revisions was 1.5 for implant reconstructions; 1.6 for LDs; 0.9 for TRAMs' and 0.8 for DIEPs'. There were significantly more revisions of implant reconstructions than DIEPs (P=0.037) and significantly more revisions of LDs compared to TRAM and DIEPs' (P=0.012 and 0.0023). In our study, the cost of an LD, TRAM or DIEP reconstruction including both primary surgery and any revisions was similar, and while at an average of three years, the implant reconstruction remains cheaper, that patient will still require more revisions, and if followed up enough will lose this small financial benefit. Furthermore, the difference is small (£8034 for implants vs. £10910 for DIEPs), and it could be argued this is justified by the increased patient satisfaction and cosmetic outcome. Finally we highlight several areas of financial inequality, including insufficient remuneration for providing individual operations, the lack of payment for performing more than one procedure at the same time and lack of payment for bilateral procedures.


Asunto(s)
Implantación de Mama/economía , Neoplasias de la Mama/cirugía , Mamoplastia/economía , Colgajos Quirúrgicos/economía , Implantación de Mama/estadística & datos numéricos , Neoplasias de la Mama/economía , Costos y Análisis de Costo , Femenino , Humanos , Tiempo de Internación/estadística & datos numéricos , Mamoplastia/estadística & datos numéricos , Persona de Mediana Edad , Estudios Retrospectivos , Reino Unido
11.
Eye (Lond) ; 21(10): 1344-51, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17914438

RESUMEN

Over the last decade there have been major advances in our understanding of the molecular pathology of inherited retinal dystrophies. This paper reviews recent advances in the identification of genetic mutations underlying infantile-onset inherited retinal disorders and considers how this knowledge may lead to novel therapeutic approaches.


Asunto(s)
Enfermedades Hereditarias del Ojo/genética , Degeneración Retiniana/genética , Defectos de la Visión Cromática/genética , Enfermedades Hereditarias del Ojo/terapia , Humanos , Lactante , Mutación , Ceguera Nocturna/genética , Degeneración Retiniana/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA